Jean-Philippe Combal is the founder of Vivet Therapeutics. Vivet Therapeutics has raised $41M in total funding. Latest round: Series A.
Jean-Philippe Combal is the Co-Founder and Chief Executive Officer of Vivet Therapeutics, a biotechnology company focused on developing gene therapies for rare, inherited metabolic diseases like Wilson disease. He oversees the clinical development of VTX-801 and manages strategic partnerships.
Full founder directory · Investor directory · Company funding database · Fundraising library